Veracyte Inc VCYT:NASDAQ

RT Quote | Last NASDAQ LS, VOL From CTA | USD
after hours iconAfter Hours: Last | 7:28 PM EDT
22.51quote price arrow up+0.01 (+0.04%)
Volume
260,974
Close
22.50quote price arrow up+1.13 (+5.29%)
Volume
1,085,435
52 week range
18.61 - 30.52
Loading...
  • Open21.54
  • Day High22.96
  • Day Low21.54
  • Prev Close21.37
  • 52 Week High30.52
  • 52 Week High Date07/18/23
  • 52 Week Low18.61
  • 52 Week Low Date04/18/24

Key Stats

  • Market Cap1.72B
  • Shares Out76.45M
  • 10 Day Average Volume0.72M
  • Dividend-
  • Dividend Yield-
  • Beta1.71
  • YTD % Change-18.21

KEY STATS

  • Open21.54
  • Day High22.96
  • Day Low21.54
  • Prev Close21.37
  • 52 Week High30.52
  • 52 Week High Date07/18/23
  • 52 Week Low18.61
  • 52 Week Low Date04/18/24
  • Market Cap1.72B
  • Shares Out76.45M
  • 10 Day Average Volume0.72M
  • Dividend-
  • Dividend Yield-
  • Beta1.71
  • YTD % Change-18.21

RATIOS/PROFITABILITY

  • EPS (TTM)-0.93
  • P/E (TTM)-24.07
  • Fwd P/E (NTM)-82.42
  • EBITDA (TTM)13.523M
  • ROE (TTM)-6.20%
  • Revenue (TTM)375.473M
  • Gross Margin (TTM)68.54%
  • Net Margin (TTM)-18.16%
  • Debt To Equity (MRQ)0.01%

EVENTS

  • Earnings Date08/06/2024(est)
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Veracyte Inc

 

Profile

MORE
Veracyte, Inc. is a global diagnostics company. The Company enables clinicians with insights they need to guide and assure patients. The Company offers tests for thyroid cancer (Afirma), prostate cancer (Decipher Prostate), breast cancer (Prosigna), interstitial lung diseases (Envisia), and bladder cancer (Decipher Bladder). Its Percepta Nasal Swab test is being run in its Clinical Laboratory Improvement Amendments (CLIA) lab in support of clinical studies and its tests for...
Robert Epstein M.D.
Independent Chairman of the Board
Marc Stapley
Chief Executive Officer, Director
Rebecca Chambers
Chief Financial Officer
Address
6000 Shoreline Court, Suite 300
South San Francisco, CA
94080
United States

Top Peers

SYMBOLLASTCHG%CHG
PTGX
Protagonist Therapeutics Inc
29.32+1.09+3.86%
CPRX
Catalyst Pharmaceuticals Inc
16.22+0.28+1.76%
BEAM
Beam Therapeutics Inc
24.02+2.76+12.98%
ADMA
ADMA Biologics Inc
8.79-0.02-0.23%
ZLAB
Zai Lab Ltd
21.52+1.44+7.17%